http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111647080-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
filingDate | 2020-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111647080-B |
titleOfInvention | C-line antibody for immune colloidal gold mixed labeling and application thereof |
abstract | The invention discloses a C-line antibody for immune colloidal gold mixed labeling and application thereof, belonging to the technical field of immune colloidal gold. The C line antibody is bovine serum albumin antibody; the amino acid sequence of the heavy chain of the C-line antibody comprises the amino acid sequence shown as SEQ ID NO: 1; the amino acid sequence of the light chain of the C-line antibody comprises the amino acid sequence shown as SEQ ID NO: 2, or a pharmaceutically acceptable salt thereof. The C-line antibody can be prepared into a sample mixed solution with a sample to be marked for immune colloidal gold marking, and the pH value of the marking is 7.8-8.4. The invention can realize the combination with real C line goat anti-mouse by mixing the bovine serum albumin antibody with the sample to be marked, thereby increasing the length-reduction transformation of the strength of the T line and the C line, improving the sensitivity of the lateral chromatography detection and avoiding the occurrence of false positive. |
priorityDate | 2020-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 332.